WHAT WE DO
WBB Securities is a leading investment management, investment banking, and equity research firm.  Established in 2001 and headquartered in San Diego, WBB Securities is a registered independent broker-dealer and investment advisor with proprietary trading desks that have market-making capabilities.  WBB Securities has built a nationwide team of respected senior investment and research professionals with a network of branches throughout the U.S. to serve institutional and high net worth clients.
 
The firm also maintains an investment banking and equity research practice focused exclusively in the life sciences niche.  Our investment bank has participated in over 120 transactions leading to $2 billion placed.  Whether raising capital or executing strategic transactions, our banking team is equipped to meet your financial needs and is comprised of some of the most knowledgeable people working in the life sciences domain.  Our firm has been distinguished from it peers for its equity research and analytics year after year for accuracy and performance by the financial industry's most highly regarded rankings organizations. 
 
OUR AREAS
INVESTMENT MANAGEMENT

Our Financial Advisors are skilled strategists and experts in financial planning, portfolio construction and investment management.

m&a AND STRATEGIC ADVISORY

We have the relationships and analytics in place to power your M&A needs through our strategic transactions unit.  

INVESTMENT BANKING

Our investment banking practice is focused in the field of life sciences and is comprised of a team of the best specialists in the field.  

institutional sales

Our sales and trading professionals can assist you to meet all of your institutional equity sales requirements.

equity research

We cover the most dynamic life sciences companies in the industry, and are continuously recognized for research performance.

EQUITY Capital Markets

We offer a full spectrum of innovative products and services to meet your capital needs.

PRESS RELEASES

VIEW ALL

WBB Securities Co-Manages $10.3MM Public Offering for CytoSorbents Corporation

CytoSorbents announces closing of public offering to fund ongoing commercial and clinical activities
CONTINUE READING

WBB Securities Announces Michelle Thomas Elected to FINRA District 2 Committee

WBB Securities is pleased to announce that Michelle Thomas, CRCPhas been elected to the FINRA District 2 Committee where she…
CONTINUE READING

WBB Securities Acts as Financial Advisor to NeoStem, Inc. on $20MM Debt Facility

NeoStem announces $20 million term loan financing from Oxford Finance LLC
CONTINUE READING

OPINIONS & FEATURES

VIEW ALL

Harvard Professors Balk As Obamacare Comes To Cambridge

Challenging Obamacare is sure to be one of the top priorities of the newly convened 2015 Congress.
CONTINUE READING

Analyst Interview with Steve Brozak: Will Biotech Fire on All Cylinders in 2015?

Making predictions for the New Year may feel as productive as peering into a crystal ball. But in the life…
CONTINUE READING

Merck Triggers The Race to Replace Cubist

A real healthcare crisis has been in the works for the last half-century and it has nothing to do with…
CONTINUE READING